QbD Business & Communications Press Releases

Published on December 6, 2021 - 07:00 GMT

New start-up Trince raises EUR 4M for technology to produce personalized cancer therapies safer, cheaper, and faster

GHENT, BELGIUM, December 6, 2021 /⁨EINPresswire.com⁩/ -- Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on October 12, 2021 - 06:00 GMT

Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment

HEUSDEN-ZOLDER, BELGIUM, October 12, 2021 /⁨EINPresswire.com⁩/ -- Rejuvenate Biomed NV (‘Rejuvenate’), a biomedical company developing novel combination drugs for age-related diseases, today announces a EUR 15.7 million Series B round. The funding is being …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on September 9, 2021 - 06:00 GMT

Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform

BRUSSELS, BELGIUM, September 9, 2021 /⁨EINPresswire.com⁩/ -- Newton Biocapital (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the treatment and prevention of chronic diseases, has announced its new investment in PRISM …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 8, 2021 - 06:00 GMT

Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders

GHENT, BELGIUM, July 8, 2021 /⁨EINPresswire.com⁩/ -- Azalea Vision, a joint spin-off from imec and Ghent University, and pioneer in the development of HealthTech smart solutions for people with vision disorders, announces the closing of its € 8 million …

Distribution channels: Banking, Finance & Investment Industry, Electronics Industry ...

Published on July 1, 2021 - 06:00 GMT

Newton Biocapital invests in EditForce to develop a unique DNA/RNA editing platform based on PPR protein technology

TOKYO, JAPAN, July 1, 2021 /⁨EINPresswire.com⁩/ -- Newton Biocapital (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the treatment and prevention of chronic diseases, has announced its follow-up investment in EditForce …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on June 22, 2021 - 06:00 GMT

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

BRUSSELS, BELGIUM, June 22, 2021 /⁨EINPresswire.com⁩/ -- Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe and Japan focused on chronic diseases, has announced its investment in a new Walloon start-up of the ULB: NeuVasQ …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 14, 2021 - 06:00 GMT

Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics

LEUVEN, BELGIUM, June 14, 2021 /⁨EINPresswire.com⁩/ -- Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the interactions between perivascular macrophages and the tumor …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 11, 2021 - 06:00 GMT

Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team

Droia Ventures, a specialist biotech investor focusing on therapeutics for oncology and genetic diseases, announces the closing of its third fund. BRUSSELS, BELGIUM, May 11, 2021 /⁨EINPresswire.com⁩/ -- Droia Ventures today announced the final closing of …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 4, 2021 - 06:00 GMT

Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch

Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. LEUVEN, BELGIUM, May 4, 2021 /⁨EINPresswire.com⁩/ -- Pulsify Medical is a digital medical technology company developing wearable ultrasound patches …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on April 27, 2021 - 06:00 GMT

PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics

Microfluidic chips for use in high-resolution nanoLC/MS workflows GHENT, BELGIUM, April 27, 2021 /⁨EINPresswire.com⁩/ -- PharmaFluidics NV, innovative life sciences instruments player, is excited to announce a step change in its product offering, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 31, 2021 - 06:00 GMT

Montis Biosciences appoints René Hoet as Chief Scientific Officer

Dr. Hoet brings 25 years of antibody research and development leadership to his new position as Montis Biosciences’ CSO LEUVEN , BELGIUM, March 31, 2021 /⁨EINPresswire.com⁩/ -- MONTIS BIOSCIENCES, a discovery stage biotech company focused on the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 23, 2021 - 07:00 GMT

Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

LEUVEN, BELGIUM, March 23, 2021 /⁨EINPresswire.com⁩/ -- Augustine Therapeutics, a biotech spin-out company from VIB that focuses on the development of novel innovative therapies for rare peripheral neuropathies and neurogenerative disorders, has received …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 19, 2021 - 07:00 GMT

Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board

LEUVEN, BELGIUM, March 19, 2021 /⁨EINPresswire.com⁩/ -- Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare peripheral neuropathies and neurodegenerative diseases, announces the strengthening of the company …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 18, 2021 - 07:00 GMT

Augustine Therapeutics appoints Sylvain Celanire as CEO

Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases. LEUVEN, BELGIUM, March 18, 2021 /⁨EINPresswire.com⁩/ -- Augustine Therapeutics, a biotech company focused on the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 2, 2021 - 07:00 GMT

Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products

HEUSDEN-ZOLDER, BELGIUM, March 2, 2021 /⁨EINPresswire.com⁩/ -- Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces it has completed a EUR 3.2 million Series A round. The funding is …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on February 24, 2021 - 07:00 GMT

Newton Biocapital invests in Flemish start-up DeuterOncology

BRUSSELS, BELGIUM, February 24, 2021 /⁨EINPresswire.com⁩/ -- Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and Japan focused on chronic diseases, has announced investment in DeuterOncology. Newton Biocapital’s …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on February 17, 2021 - 07:00 GMT

PharmaFluidics Announces Ultra-Sensitive Second Generation µPAC™ Technology for Unbiased Single Cell Proteomics

Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level GHENT, BELGIUM, February 17, 2021 /⁨EINPresswire.com⁩/ -- PharmaFluidics NV, innovative life sciences instruments player, is excited to announce …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 4, 2021 - 07:00 GMT

V-Bio Ventures launches its second fund at EUR 78 million

GHENT, BELGIUM, February 4, 2021 /⁨EINPresswire.com⁩/ -- • First Closing of V-Bio Fund 2 is announced at EUR 78 million • V-Bio Fund 2 will ensure seamless continuation of investment activities in early-stage European life sciences companies • V-Bio …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on February 1, 2021 - 11:52 GMT

DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy

DIEPENBEEK, BELGIUM, February 1, 2021 /⁨EINPresswire.com⁩/ -- DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for radiation therapy, today announces the CE marking of its first product: the DoseWire™ Series 200 …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on December 1, 2020 - 07:00 GMT

Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for blood cancers

BRUSSELS, BELGIUM, December 1, 2020 /⁨EINPresswire.com⁩/ -- Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the treatment and prevention of chronic diseases, has announced its third investment in …

Distribution channels: Business & Economy, Companies ...

The Newsroom of QbD Business & Communications